Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

  1. Singer, B.A.
  2. Arnold, D.L.
  3. Drulovic, J.
  4. Freedman, M.S.
  5. Gold, R.
  6. Gudesblatt, M.
  7. Jasinska, E.
  8. LaGanke, C.C.
  9. Naismith, R.T.
  10. Negroski, D.
  11. Oh, J.
  12. Hernandez Perez, M.A.
  13. Selmaj, K.
  14. Then Bergh, F.
  15. Wundes, A.
  16. Ziemssen, T.
  17. Castro-Borrero, W.
  18. Chen, H.
  19. Levin, S.
  20. Scaramozza, M.
  21. Shankar, S.L.
  22. Wang, T.
  23. Wray, S.
Revue:
Multiple Sclerosis Journal

ISSN: 1477-0970,  1352-4585

Année de publication: 2023

Volumen: 29

Número: 14

Pages: 1795-1807

Type: Article

DOI: 10.1177/13524585231205708 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus